Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018

Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018

Summary

The Medical Devices sector report, Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018" provides an overview of Cervical Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cervical Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by The team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Cervical Cancer Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Cervical Cancer Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry.

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Cervical Cancer Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date.


1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Cervical Cancer Diagnostic Tests Overview 7
3 Products under Development 8
3.1 Cervical Cancer Diagnostic Tests - Pipeline Products by Stage of Development 8
3.2 Cervical Cancer Diagnostic Tests - Pipeline Products by Territory 9
3.3 Cervical Cancer Diagnostic Tests - Pipeline Products by Regulatory Path 10
3.4 Cervical Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date 11
3.5 Cervical Cancer Diagnostic Tests - Ongoing Clinical Trials 12
4 Cervical Cancer Diagnostic Tests - Pipeline Products under Development by Companies 13
4.1 Cervical Cancer Companies - Pipeline Products by Stage of Development 13
4.2 Cervical Cancer Diagnostic Tests - Pipeline Products by Stage of Development 14
5 Cervical Cancer Diagnostic Tests Companies and Product Overview 15
5.1 Alere Inc Company Overview 15
5.2 Augusta University Company Overview 16
5.3 Becton Dickinson and Co Company Overview 17
5.4 Bio Techne Corp Company Overview 21
5.5 BioAffinity Technologies, Inc. Company Overview 22
5.6 BioMark Diagnostics Inc. Company Overview 23
5.7 BioMark Technologies Inc Company Overview 24
5.8 Cepheid Company Overview 25
5.9 China Sky One Medical Inc Company Overview 26
5.10 Cytosystems Ltd Company Overview 27
5.11 Enzo Biochem Inc Company Overview 28
5.12 GenomicTree Inc Company Overview 29
5.13 GRANT Life Sciences, Inc. Company Overview 31
5.14 Louisville Bioscience, Inc. Company Overview 32
5.15 MDNA Life Sciences Inc Company Overview 33
5.16 MDxHealth SA Company Overview 34
5.17 Milagen Inc Company Overview 35
5.18 Olympia Diagnostics, Inc Company Overview 36
5.19 Oncgnostics GmbH Company Overview 38
5.20 ONCOVEDA Cancer Research Center Company Overview 40
5.21 Precision Biologics Inc Company Overview 41
5.22 US Biomarkers Inc Company Overview 42
5.23 XEPTAGEN SpA Company Overview 43
6 Cervical Cancer Diagnostic Tests Recent Developments 44
6.1 Jun 27, 2018: BD, Heart to Heart International and the NAFC Announce 2018 Grantees for a Multi-Year Point of Care Testing Initiative to Improve Patient Outcomes 44
6.2 Jun 12, 2018: Agilent Companion Diagnostic Gains Expanded FDA Approval in Cervical Cancer 45
6.3 Jun 12, 2018: Cancer Genetics Appoints Michael McCartney As Chief Commercial Officer 45
6.4 Jun 05, 2018: Study Finds Older Patients Who Undergo Mammography Also Are More Likely to Pursue Other Preventive Tests 46
6.5 Jun 01, 2018: BD Appoints John DeFord As Chief Technology Officer 47
6.6 May 17, 2018: Quest Diagnostics adds Helen Torley to Board of Directors 47
6.7 May 15, 2018: Cancer Genetics Reports First Quarter 2018 Financial Results and Provides Strategic Business Updates 48
6.8 May 14, 2018: bioAffinity Technologies Welcomes Peter S. Knight to Board of Directors 50
6.9 May 07, 2018: Forbes Names Quest Diagnostics One of Americas Best Large Employers 50
6.10 May 06, 2018: Kaskela Law: Shareholder Class Action Filed Against Cancer Genetics 51
6.11 May 03, 2018: BD Announces Results For 2018 Second Fiscal Quarter; Raises Fiscal 2018 Guidance 51
7 Appendix 94
7.1 Methodology 94
7.2 About GlobalData 97
7.3 Contact Us 97
7.4 Disclaimer 97

List Of Tables

1.1 List of Tables
Table 1: Cervical Cancer Diagnostic Tests - Pipeline Products by Stage of Development 8
Table 2: Cervical Cancer Diagnostic Tests - Pipeline Products by Territory 9
Table 3: Cervical Cancer Diagnostic Tests - Pipeline Products by Regulatory Path 10
Table 4: Cervical Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date 11
Table 5: Cervical Cancer Diagnostic Tests - Ongoing Clinical Trials 12
Table 6: Cervical Cancer Companies - Pipeline Products by Stage of Development 13
Table 7: Cervical Cancer Diagnostic Tests - Pipeline Products by Stage of Development 14
Table 8: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 15
Table 9: NMP179 Test - Product Status 15
Table 10: NMP179 Test - Product Description 15
Table 11: Augusta University Pipeline Products & Ongoing Clinical Trials Overview 16
Table 12: Folate Receptor Biomarker Test - Cervical Cancer Diagnostic Tests - Product Status 16
Table 13: Folate Receptor Biomarker Test - Cervical Cancer Diagnostic Tests - Product Description 16
Table 14: Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 17
Table 15: BD SurePath Plus Molecular Pap Test System - Product Status 17
Table 16: BD SurePath Plus Molecular Pap Test System - Product Description 17
Table 17: Biomarker Test - Cervical Cancer Diagnostic Tests - Product Status 18
Table 18: Biomarker Test - Cervical Cancer Diagnostic Tests - Product Description 18
Table 19: Becton Dickinson and Co - Ongoing Clinical Trials Overview 19
Table 20: BD SurePath Plus Molecular Pap Test System - Validation of High Resolution Microendoscope in the Screening of Cervical Cancer Precursor Lesions in Brazil: UH3 - Brazil 20
Table 21: Bio Techne Corp Pipeline Products & Ongoing Clinical Trials Overview 21
Table 22: RNAscope HPV Assay - Cervical Cancer Diagnostic Tests - Product Status 21
Table 23: RNAscope HPV Assay - Cervical Cancer Diagnostic Tests - Product Description 21
Table 24: BioAffinity Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
Table 25: CyPath Diagnostic Assay - Cervical Cancer Diagnostic Tests - Product Status 22
Table 26: CyPath Diagnostic Assay - Cervical Cancer Diagnostic Tests - Product Description 22
Table 27: BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
Table 28: Metabolomics-based Diagnostic Assay - Cervical Cancer Diagnostic Tests - Product Status 23
Table 29: Metabolomics-based Diagnostic Assay - Cervical Cancer Diagnostic Tests - Product Description 23
Table 30: BioMark Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 24
Table 31: Biomarker Assay - Cervical Cancer Diagnostic Tests - Product Status 24
Table 32: Biomarker Assay - Cervical Cancer Diagnostic Tests - Product Description 24
Table 33: Cepheid Pipeline Products & Ongoing Clinical Trials Overview 25
Table 34: Xpert Molecular PAP Assay - Product Status 25
Table 35: Xpert Molecular PAP Assay - Product Description 25
Table 36: China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 26
Table 37: Diagnostic Kit - Carcinoma Cervix - Product Status 26
Table 38: Diagnostic Kit - Carcinoma Cervix - Product Description 26
Table 39: Cytosystems Ltd Pipeline Products & Ongoing Clinical Trials Overview 27
Table 40: Laboratory-Based Diagnostic Test - Cervical Cancer Diagnostic Tests - Product Status 27
Table 41: Laboratory-Based Diagnostic Test - Cervical Cancer Diagnostic Tests - Product Description 27
Table 42: Enzo Biochem Inc Pipeline Products & Ongoing Clinical Trials Overview 28
Table 43: p16 Biomarker - Cervical Cancer Diagnostic Tests - Product Status 28
Table 44: p16 Biomarker - Cervical Cancer Diagnostic Tests - Product Description 28
Table 45: GenomicTree Inc Pipeline Products & Ongoing Clinical Trials Overview 29
Table 46: EarlyTect Cervical Cancer Diagnostic Tests - Product Status 29
Table 47: EarlyTect Cervical Cancer Diagnostic Tests - Product Description 29
Table 48: Screening Test - Cervical Cancer Diagnostic Tests - Product Status 30
Table 49: Screening Test - Cervical Cancer Diagnostic Tests - Product Description 30
Table 50: GRANT Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
Table 51: Serum-Based Test - Cervical Cancer Diagnostic Tests - Product Status 31
Table 52: Serum-Based Test - Cervical Cancer Diagnostic Tests - Product Description 31
Table 53: Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
Table 54: Cervical Cancer Remission pT Test - Product Status 32
Table 55: Cervical Cancer Remission pT Test - Product Description 32
Table 56: MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 57: Cervical Mitomic Test - Product Status 33
Table 58: Cervical Mitomic Test - Product Description 33
Table 59: MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview 34
Table 60: ClinicalMDx - Cervical Cancer Diagnostic Tests - Product Status 34
Table 61: ClinicalMDx - Cervical Cancer Diagnostic Tests - Product Description 34
Table 62: Milagen Inc Pipeline Products & Ongoing Clinical Trials Overview 35
Table 63: Immunoassay - Cervical Cancer Diagnostic Tests - Product Status 35
Table 64: Immunoassay - Cervical Cancer Diagnostic Tests - Product Description 35
Table 65: Olympia Diagnostics, Inc Pipeline Products & Ongoing Clinical Trials Overview 36
Table 66: Diagnostic Test - Cervical Cancer Diagnostic Tests - Product Status 36
Table 67: Diagnostic Test - Cervical Cancer Diagnostic Tests - Product Description 36
Table 68: Prognostic Test - Cervical Cancer Diagnostic Tests - Product Status 37
Table 69: Prognostic Test - Cervical Cancer Diagnostic Tests - Product Description 37
Table 70: Oncgnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 38
Table 71: GynTect - Product Status 38
Table 72: GynTect - Product Description 38
Table 73: GynTect 2.0 - Product Status 39
Table 74: GynTect 2.0 - Product Description 39
Table 75: ONCOVEDA Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 40
Table 76: HPV Companion Diagnostic Test - Cervical Cancer Diagnostic Tests - Product Status 40
Table 77: HPV Companion Diagnostic Test - Cervical Cancer Diagnostic Tests - Product Description 40
Table 78: Precision Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview 41
Table 79: Diagnostic Assay - Cervical Cancer Diagnostic Tests - Product Status 41
Table 80: Diagnostic Assay - Cervical Cancer Diagnostic Tests - Product Description 41
Table 81: US Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview 42
Table 82: Blood-Based Biomarker - Cervical Cancer Diagnostic Tests - Product Status 42
Table 83: Blood-Based Biomarker - Cervical Cancer Diagnostic Tests - Product Description 42
Table 84: XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview 43
Table 85: SCCA - IgM Kit - Cervical Cancer Diagnostic Tests - Product Status 43
Table 86: SCCA - IgM Kit - Cervical Cancer Diagnostic Tests - Product Description 43
Table 87: Glossary 96

List Of Figures

1.2 List of Figures
Figure 1: Cervical Cancer Diagnostic Tests - Pipeline Products by Stage of Development 8
Figure 2: Cervical Cancer Diagnostic Tests - Pipeline Products by Territory 9
Figure 3: Cervical Cancer Diagnostic Tests - Pipeline Products by Regulatory Path 10
Figure 4: Cervical Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date 11
Figure 5: Cervical Cancer Diagnostic Tests - Ongoing Clinical Trials 12

Global TCT Cervical Cancer Screening Market Research Report 2020-2024

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. TCT Cervical Cancer Screening Report by Material, Application,

USD 2850 View Report

Cervical Cancer - Pipeline Review, H2 2019

Cervical Cancer - Pipeline Review, H2 2019latest Pharmaceutical and Healthcare disease pipeline guide Cervical Cancer - Pipeline Review, H2 2019, provides an overview of the Cervical Cancer (Oncology) pipeline landscape.Cervical

USD 2000 View Report

Global TCT Cervical Cancer Screening Market Research Report 2020-2024

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. TCT Cervical Cancer Screening Report by Material, Application,

USD 2850 View Report

Cervical Cancer - Pipeline Review, H2 2019

Cervical Cancer - Pipeline Review, H2 2019latest Pharmaceutical and Healthcare disease pipeline guide Cervical Cancer - Pipeline Review, H2 2019, provides an overview of the Cervical Cancer (Oncology) pipeline landscape.Cervical

USD 2000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available